Payment overview · 2025
General Payments
$205.49
5 reported records · 5 companies
Healthcare provider profile · identity verified
Donald K Ware, DO
Allopathic & Osteopathic Physicians|Family Medicine · SEBRING, FL · NPI 1598787210
Verified facts
What the public records show
CMS Open Payments records show Donald K Ware, DO received $205.49 in general payments during 2025 across 5 reported records.
INTUITIVE SURGICAL, INC. accounted for 50.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Trelegy Ellipta by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 40 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| INTUITIVE SURGICAL, INC. | Unresolved — no canonical attribution shown | $103.23 | 50.2% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $27.92 | 13.6% | 1 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $26.25 | 12.8% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $24.67 | 12.0% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $23.42 | 11.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $205.49 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Da Vinci Surgical System Normalized: da vinci surgical system |
Device | INTUITIVE SURGICAL, INC. | $103.23 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $27.92 | 1 | 2025 |
Source payment records
|
|||||
| Holter Normalized: holter |
Device | Philips North America LLC | $26.25 | 1 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $24.67 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $23.42 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 30 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
40 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
28 | 11 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 815 | 227 |
| Lisinopril | Lisinopril | 561 | 152 |
| Amlodipine Besylate | Amlodipine Besylate | 509 | 147 |
| Omeprazole | Omeprazole | 487 | 131 |
| Gabapentin | Gabapentin | 416 | 125 |
| Levothyroxine Sodium | Levothyroxine Sodium | 405 | 116 |
| Metoprolol Tartrate | Metoprolol Tartrate | 396 | 104 |
| Metformin Hcl | Metformin Hcl | 378 | 107 |
| Losartan Potassium | Losartan Potassium | 368 | 107 |
| Fluticasone Propionate | Fluticasone Propionate | 313 | 113 |
| Alprazolam | Alprazolam | 298 | 57 |
| Meloxicam | Meloxicam | 258 | 73 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 251 | 79 |
| Montelukast Sodium | Montelukast Sodium | 224 | 61 |
| Simvastatin | Simvastatin | 224 | 62 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 214 | 59 |
| Pantoprazole Sodium | Pantoprazole Sodium | 212 | 67 |
| Tramadol Hcl | Tramadol Hcl | 210 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 208 | 66 |
| Prednisone | Prednisone | 207 | 97 |
| Trazodone Hcl | Trazodone Hcl | 191 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 188 | 59 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 181 | 35 |
| Hydrochlorothiazide | Hydrochlorothiazide | 179 | 53 |
| Furosemide | Furosemide | 171 | 52 |
| Potassium Chloride | Potassium Chloride | 170 | 46 |
| Famotidine | Famotidine | 162 | 44 |
| Clopidogrel | Clopidogrel Bisulfate | 155 | 51 |
| Sertraline Hcl | Sertraline Hcl | 153 | 36 |
| Clonazepam | Clonazepam | 147 | 20 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 138 | 43 |
| Carvedilol | Carvedilol | 136 | 40 |
| Glipizide | Glipizide | 123 | 34 |
| Alendronate Sodium | Alendronate Sodium | 116 | 31 |
| Eliquis | Apixaban | 115 | 41 |
| Allopurinol | Allopurinol | 114 | 37 |
| Lorazepam | Lorazepam | 107 | 25 |
| Paroxetine Hcl | Paroxetine Hcl | 96 | 28 |
| Ropinirole Hcl | Ropinirole Hcl | 90 | 26 |
| Pravastatin Sodium | Pravastatin Sodium | 86 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 83 | 24 |
| Ibuprofen | Ibuprofen | 76 | 21 |
| Baclofen | Baclofen | 74 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 74 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 74 | 20 |
| Atenolol | Atenolol | 70 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 70 | 20 |
| Meclizine Hcl | Meclizine Hcl | 70 | 20 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 69 | 60 |
| Quetiapine Fumarate | Quetiapine Fumarate | 69 | 18 |
| Azithromycin | Azithromycin | 66 | 53 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 65 | 17 |
| Ozempic | Semaglutide | 64 | 16 |
| Donepezil Hcl | Donepezil Hcl | 63 | 18 |
| Finasteride | Finasteride | 62 | 17 |
| Ezetimibe | Ezetimibe | 61 | 18 |
| Temazepam | Temazepam | 60 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 59 | 18 |
| Glimepiride | Glimepiride | 57 | 18 |
| Symbicort | Budesonide/Formoterol Fumarate | 56 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 56 | 14 |
| Topiramate | Topiramate | 55 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 54 | 17 |
| Januvia | Sitagliptin Phosphate | 52 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 51 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 48 | 13 |
| Pregabalin | Pregabalin | 46 | 17 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 45 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 45 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 44 | 11 |
| Fenofibrate | Fenofibrate | 43 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 43 | 12 |
| Cefuroxime | Cefuroxime Axetil | 42 | 29 |
| Glipizide Er | Glipizide | 41 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 41 | suppressed |
| Diazepam | Diazepam | 40 | suppressed |
| Jardiance | Empagliflozin | 40 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 38 | suppressed |
| Naproxen | Naproxen | 38 | suppressed |
| Dutasteride | Dutasteride | 36 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 36 | suppressed |
| Spironolactone | Spironolactone | 36 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 36 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 35 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 33 | 11 |
| Mirtazapine | Mirtazapine | 33 | suppressed |
| Celecoxib | Celecoxib | 32 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 32 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 32 | suppressed |
| Xarelto | Rivaroxaban | 32 | suppressed |
| Fluconazole | Fluconazole | 31 | 17 |
| Primidone | Primidone | 31 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 30 | suppressed |
| Ranolazine Er | Ranolazine | 30 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 30 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 30 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 29 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 28 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 28 | suppressed |
| Nitroglycerin | Nitroglycerin | 28 | 17 |
| Testosterone Cypionate | Testosterone Cypionate | 28 | suppressed |
| Trulicity | Dulaglutide | 28 | 11 |
| Aripiprazole | Aripiprazole | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 27 | 12 |
| Chlorthalidone | Chlorthalidone | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | 14 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 25 | suppressed |
| Ketoconazole | Ketoconazole | 25 | suppressed |
| Novolin R | Insulin Regular, Human | 25 | suppressed |
| Novolog Flexpen | Insulin Aspart | 25 | suppressed |
| Synthroid | Levothyroxine Sodium | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 24 | suppressed |
| Gemfibrozil | Gemfibrozil | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Methocarbamol | Methocarbamol | 24 | 11 |
| Sildenafil Citrate | Sildenafil Citrate | 24 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Rivastigmine | Rivastigmine | 23 | suppressed |
| Brilinta | Ticagrelor | 22 | suppressed |
| Levetiracetam | Levetiracetam | 22 | suppressed |
| Nifedipine Er | Nifedipine | 22 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 22 | suppressed |
| Anastrozole | Anastrozole | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 21 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Acyclovir | Acyclovir | 19 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Ibu | Ibuprofen | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Cilostazol | Cilostazol | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Droplet Insulin Syringe | Syringe And Needle,insulin,1ml | 17 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Amoxicillin | Amoxicillin | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 15 | suppressed |
| Estradiol | Estradiol | 15 | suppressed |
| Klor-Con 10 | Potassium Chloride | 15 | suppressed |
| Methotrexate | Methotrexate Sodium | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 14 | suppressed |
| Jantoven | Warfarin Sodium | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Sucralfate | Sucralfate | 13 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Cephalexin | Cephalexin | 11 | 11 |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 11 | suppressed |
| Humulin R U-500 | Insulin Regular, Human | 11 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $205.49 · 5 records | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System, Holter, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, ZEPBOUND | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error